Insights+

Insights+: EMA Marketing Authorization of New Drugs in February 2023

Insights+: EMA Marketing Authorization of New Drugs in February 2023

Shots: The EMA approved 7 New Chemical Entity (NCE) and 5 Biologic Drugs in Februa...

Top Performing Drug of 2021 - Darzalex (March Edition)

Top Performing Drug of 2021 - Darzalex (March Edition)

Shots: The ongoing series of the top-performing drugs of 2021 based on revenue is...

Insights+: The US FDA New Drug Approvals in February 2023

Insights+: The US FDA New Drug Approvals in February 2023

Shots: The US FDA approved 5 NDAs and 5 BLA in February 2023, leading to treatment...

Disease of the Month: IgA Nephropathy

Disease of the Month: IgA Nephropathy

Shots: To create a wholesome environment for the current and the future generation...

Insights+ Key Biosimilars Events of February 2023

Insights+ Key Biosimilars Events of February 2023

Shots: Biosimilars are developed to be highly similar versions of approved biologi...

Insights+: EMA Marketing Authorization of New Drugs in January 2023

Insights+: EMA Marketing Authorization of New Drugs in January 2023

Shots: The EMA approved 3 New Chemical Entity (NCE) and 5 Biologic Drugs in Januar...

Image